Ruch Brianna, Limkemann Ashley J, Garcia Paulo, Benedict Cameron, Gupta Gaurav, Levy Marlon, Sharma Amit
Hume-Lee Transplant Center, Virginia Commonwealth University, Richmond, VA, USA.
Department of Pathology, Virginia Commonwealth University, Richmond, VA, USA.
Case Rep Nephrol. 2020 Oct 14;2020:7145652. doi: 10.1155/2020/7145652. eCollection 2020.
Tubulocystic renal cell carcinoma (TCC) is a rare and newly recognized variant of renal cell carcinoma, which may mimic benign cystic disease of the kidney. To our knowledge, we present the first reported case of a patient who, despite standard preoperative workup, developed TCC of his native kidney soon after receiving kidney transplantation. He was appropriately treated with native nephrectomy and has had no signs of reoccurrence 7 years postoperatively. Given the significant risk of malignancy in renal transplant patients, this case emphasizes the need for close monitoring of native cystic disease before and after transplantation, with low threshold to proceed with surgical intervention.
肾小管囊性肾细胞癌(TCC)是一种罕见且新认识的肾细胞癌变异型,可能酷似肾脏良性囊性疾病。据我们所知,我们报告了首例患者,尽管术前进行了标准检查,但在接受肾移植后不久,其原生肾发生了TCC。他接受了患肾切除术,术后7年无复发迹象。鉴于肾移植患者存在显著的恶性肿瘤风险,该病例强调了在移植前后密切监测原生囊性疾病的必要性,手术干预阈值应较低。